How much does Orpathys (Savolitinib Tablets) Cost& price without insurance in China?
Orpathys® is the commercial brand name of Savolitinib Tablets, an orally selective c-Met inhibitor developed by Hutchison MediPharma and AstraZeneca. It blocks the c-Met/HGF signaling pathway, inhibiting tumor cell proliferation, invasion, and angiogenesis driven by c-Met aberrations.
Main Indications
Treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutations, who have received no prior systemic therapy.
Common Side Effects
Common mild adverse reactions: Edema, nausea, vomiting, fatigue, and decreased appetite.
Laboratory abnormalities: Elevated liver enzymes, hypoalbuminemia, and thrombocytopenia.
Severe but uncommon risks: Severe hepatic toxicity, interstitial lung disease, and hemorrhage.
Approval Status in China
Orpathys® (Savolitinib Tablets) was officially approved for marketing in China in 2021. It is currently a prescription anti-tumor drug included in China’s Category B medical insurance.
Buy Orpathys (Savolitinib Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
